AmerisourceBergen Corporation
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home…
Medical - Distribution
US, Conshohocken [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
Metric | Q1 | Q2 | Δ in % | |
---|---|---|---|---|
Current Ratio | 0.45 | 0.89 | 0.88 | |
Debt/Assets | n.A. | n.A. | n.A. | |
Debt/Equity | n.A. | n.A. | n.A. | |
Net Debt/EBITDA | 57.45 | 2.77 | 1.76 | |
Naive Interpretation | member |
2
Per Share
Metric | Q1 | Q2 | Δ in % | |
---|---|---|---|---|
Book Value | 35.04 | 6.15 | 4.56 | |
Cash | -30.16 | 10.38 | 14.85 | |
Capex | -52.44 | -0.57 | -0.37 | |
Free Cash Flow | 22.64 | -4.97 | 4.05 | |
Revenue | -4.99 | 343.09 | 361.12 | |
Naive Interpretation | member |
3
Profitability
Metric | Q1 | Q2 | Δ in % | |
---|---|---|---|---|
Gross Margin | 11.33 | 0.03 | 0.03 | |
Operating Margin | 23.36 | 0.01 | 0.01 | |
ROA | -29.15 | < 0.005 | < 0.005 | |
ROE | -48.02 | 0.34 | 0.66 | |
ROIC | 20.24 | 0.12 | 0.10 | |
Naive Interpretation | member |
4
Valuation
The "Valuation Entry" for the Focus of ABC is permitted for members.
5
Growth
The "Growth Entry" for the Focus of ABC is permitted for members.
6
Leverage & Liquidity